Analyst Recommendations
Oppenheimer analyst issues UNDERPERFORM recommendation for CRNX on June 4, 2024 08:01AM ET. The previous analyst recommendation was Underperform.CRNX was trading at $46.28 at issue of the analyst...June 4, 2024 CRNX -1.63%
Mizuho Securities analyst issues UNDERPERFORM recommendation for PCOR on June 4, 2024 08:00AM ET. The previous analyst recommendation was Underperform.PCOR was trading at $65.37 at issue of the...June 4, 2024 PCOR 0.19%
Piper Sandler analyst issues BUY recommendation for PCOR on June 4, 2024 08:00AM ET. The previous analyst recommendation was Buy.PCOR was trading at $65.37 at issue of the...June 4, 2024 PCOR 0.19%
Susquehanna analyst issues BUY recommendation for LSCC on June 4, 2024 08:01AM ET. The previous analyst recommendation was Buy.LSCC was trading at $62.74 at issue of the analyst...June 4, 2024 LSCC -0.23%
Needham analyst issues UNDERPERFORM recommendation for LSCC on June 4, 2024 08:01AM ET. The previous analyst recommendation was Underperform.LSCC was trading at $62.74 at issue of the analyst...June 4, 2024 LSCC -0.23%
BMO Capital analyst issues MARKET PERFORM recommendation for D on June 4, 2024 08:04AM ET. The previous analyst recommendation was Market Perform.D was trading at $53.67 at issue...June 4, 2024 D 0.38%
Jefferies analyst issues BUY recommendation for ALKS on June 4, 2024 08:02AM ET. The previous analyst recommendation was Buy.ALKS was trading at $24.055 at issue of the analyst...June 4, 2024 ALKS -0.44%
RBC Capital analyst issues OUTPERFORM recommendation for REGN on June 4, 2024 08:02AM ET. The previous analyst recommendation was Outperform.REGN was trading at $989.48 at issue of the...June 4, 2024 REGN -0.59%
Jefferies analyst issues BUY recommendation for GSK on June 4, 2024 08:35AM ET. The previous analyst recommendation was Buy.GSK was trading at $40.88 at issue of the analyst...June 4, 2024 GSK -0.42%
Rodman & Renshaw analyst issues BUY recommendation for ANVS on June 4, 2024 08:26AM ET. ANVS was trading at $6.81 at issue of the analyst recommendation.
Historical Analyst Recommendations
Latest...June 4, 2024 ANVS 2.80%